GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $113,164,000 | -0.7% | 2,623,782 | -0.2% | 3.61% | +1.7% |
| Q2 2016 | $113,947,000 | +16.3% | 2,629,138 | +8.8% | 3.55% | +21.9% |
| Q1 2016 | $97,951,000 | +1.8% | 2,415,570 | +1.3% | 2.91% | +1.6% |
| Q4 2015 | $96,197,000 | +58.0% | 2,384,060 | +50.6% | 2.87% | +56.9% |
| Q3 2015 | $60,883,000 | -11.6% | 1,583,431 | -4.3% | 1.83% | -3.4% |
| Q2 2015 | $68,898,000 | -7.2% | 1,654,203 | +2.8% | 1.89% | -1.3% |
| Q1 2015 | $74,255,000 | +21.2% | 1,609,002 | +12.2% | 1.92% | +17.8% |
| Q4 2014 | $61,267,000 | -9.1% | 1,433,473 | -2.2% | 1.63% | -13.6% |
| Q3 2014 | $67,410,000 | -9.4% | 1,466,396 | +5.3% | 1.88% | -6.8% |
| Q2 2014 | $74,441,000 | +15.2% | 1,391,936 | +15.1% | 2.02% | -0.1% |
| Q1 2014 | $64,633,000 | +13.2% | 1,209,685 | +13.1% | 2.02% | -2.7% |
| Q4 2013 | $57,114,000 | -46.4% | 1,069,750 | -49.7% | 2.08% | -1.1% |
| Q3 2013 | $106,652,000 | +111.9% | 2,125,828 | +111.0% | 2.10% | +2.3% |
| Q2 2013 | $50,342,000 | – | 1,007,440 | – | 2.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |